Search results
Displaying 881 - 890 of 1035 results
-
Display of combination product medicines in electronic systems
Guidelines for the display of combination product medicines in electronic systems.
-
#O2TheFix toolkit
Tools developed by Waitematā DHB to encourage the safer prescribing and the best practice use of oxygen therapy, to reduce harm to patients.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidance
New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Safe use of opioids measurement: frequently asked questions
Frequently asked questions about measurement for the safe use of opioids.
-
Safe use of opioids collaborative information for DHB hospitals
Information document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
-
Safe Medication Management newsletters - 2010
Newsletters from the SMM programme for the year 2010
-
ALERT 17: Alteplase or tenecteplase?
An alert has been issued to highlight the need to clearly differentiate between stroke thrombolysis and myocardial infarction thrombolysis.
-
Evaluation of the safe use of opioids national collaborative
This report presents an evaluation of the Health Quality & Safety Commission-led safe use of opioids national collaborative.